Therapeutics(31)

  • Targeted Inhibition of ADAM17 for the Treatment of Inflammatory Diseases and Cancer (No. T4-1628)

    ADAM17 is a metalloprotease that regulates shedding of membrane-bound proteins, including IL-6, TNF-α, and others. ADAM17 is implicated in inflammatory diseases, fibrosis, cancer, and autoimmune conditions, making it a compelling target. ... Read more
    Full Professor Irit Sagi

    Irit Sagi

    Faculty of Biology

    5551

Pages

Subscribe to Therapeutics